Tech Company Financing Transactions
Release Therapeutics Funding Round
On 8/7/2024, Release Therapeutics landed $3.8 million in Seed funding from private investors.
Transaction Overview
Company Name
Announced On
8/7/2024
Transaction Type
Venture Equity
Amount
$3,800,000
Round
Seed
Investors
Proceeds Purpose
The company intends to use the funds to expand operations and its R&D sector.
Company Information
Company Status
Private & Independent
Industry
Healthcare Services
Mailing Address
Campus Biotech Innovation Park Avenue de Sécheron 15
Genève, CH 1202
Switzerland
Genève, CH 1202
Switzerland
Phone
Website
Email Address
Overview
Release Tx was launched in 2023 -- but our roots run deeper, going back to the foundation of some of the first preclinical & clinical studies of allogeneic encapsulated cell therapy. Our team has played a central role in the evolution of this technology from a promising idea to a potential life-transforming reality.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Thomas Mehrling
Chief Operating Officer
Julien Grogg
Browse more venture capital transactions:
Prev: 8/7/2024: ABH Optics venture capital transaction
Next: 8/7/2024: Anjuna Security venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to report on funding rounds that are announced publicly. VC investment data records on this site are sourced from publicly available VC deal announcements. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs